|
|
|
|
|
|
|
|
|
|
A Phase I Study of Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
With a median follow-up of 19 months (range, 2–39), 20 patients (83%) recurred and six (25%) died.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.